Pharmafile Logo
Pharmafocus logo
Advanced Search

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 13, 2023
Sales and Marketing

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

News
Press release

ANGLE plc (“the Company”) Pharma Services Contract with Crescendo Biologics

April 13, 2023
Business Services

ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce that it has signed a …

News
Press release

Transgene’s Board of Directors Proposes the Appointment of Carol Stuckley, MBA, as New Independent Director

April 13, 2023
Business Services

Strasbourg, France, April 12, 2023, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops …

Appointment

Alentis Therapeutics closes $105m Series C funding for new treatment options

April 13, 2023
Sales and Marketing

Alentis Therapeutics has announced $105m in Series C funding which was led by Jeito Capital together with Novo Holdings A/S …

News
robina-weermeijer-3kgf9r_0ohs-unsplash_2

Biogen announces licensing of Denali’s ATV to target Amyloid Beta

April 13, 2023
Research and Development

Biogen and Denali Therapeutics have announced that Biogen has exercised its option to license Denali’s Antibody Transport Vehicle: Amyloid beta …

News
minku-kang-acnintiifd8-unsplash_1

Aspect Biosystems and Novo Nordisk partner with $75m deal to develop bioprinted tissue therapeutics

April 13, 2023
Research and Development

Canadian biotech company Aspect Biosystems and Denmark-based Novo Nordisk have announced a collaboration, development and license agreement to develop bioprinted …

News
hal-gatewood-uo7xjiv4awk-unsplash

Kala Pharmaceuticals receives FDA Fast Track Designation for human MSC-S therapy

April 13, 2023
Medical Communications

Clinical-stage biopharmaceutical company Kala Pharmaceuticals has announced that the FDA has granted it Fast Track Designation for its human mesenchymal …

News

ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) ACCEPTED FOR USE WITHIN NHS SCOTLAND EARLIER IN THE TREATMENT PATHWAY FOR HER2-POSITIVE METASTATIC BREAST CANCER

April 12, 2023
Business Services

Daiichi Sankyo UK Limited and AstraZeneca UK Limited welcome the news that the Scottish Medicines Consortium (SMC) has accepted Enhertu®▼ …

News
Press release

Almirall, the first to assess wellbeing in a dermatology clinical study

April 12, 2023
Business Services

BARCELONA, Spain. April 12, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced the …

News
Press release

Liberal states begin stockpiling abortion medications following Texas court ruling

April 12, 2023
Medical Communications

Various liberal US states, including California and Massachusetts, have begun stockpiling abortion medications following a Texas judge Matthew Kacsmaryk’s attempt …

News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna announces mixed success clinical updates for mRNA pipeline

April 12, 2023
Research and Development

Biotechnology company Moderna has announced clinical updates detailing the expansion and advancement of its mRNA pipeline, which includes treatments for …

News
christina-victoria-craft-whsnkiwwpec-unsplash_4

ImaginAb signs new license and supply agreement with Leucid Bio for CD8 ImmunoPET technology

April 12, 2023
Sales and Marketing

Biotechnology company ImaginAb has announced that it has signed a new non-exclusive License and Supply Agreement (LSA) with Leucid Bio. …

News
carlos-muza-hpjsku2uysu-unsplash_1

Cognizant and Boehringer Ingelheim collaborate on integrated cloud platform to improve therapy development

April 12, 2023
Medical Communications

US-based Cognizant and biopharmaceutical company Boehringer Ingelheim have announced a partnership to collaborate on ensuring the quality, and increasing the …

News

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

April 11, 2023
Business Services

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science …

News
Press release
christina-victoria-craft-zhys6xn7sue-unsplash_5

Molecular Templates announces hold for phase 1 study

April 11, 2023
Research and Development

Molecular Templates has announced that the FDA has placed a partial hold on its phase 1 study for MT-0169 based …

News

FDA authorises marketing of MISHA Knee System for patients with knee osteoarthritis

April 11, 2023
Medical Communications

Medical device company, Moximed, has announced that the FDA granted marketing authorisation of its MISHA Knee System, an implantable shock …

News

Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD

April 11, 2023
Business Services

LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage …

News
Press release

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

April 11, 2023
Business Services

Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the first commercial …

News
Press release

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

April 6, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening …

News
Press release
christina-victoria-craft-whsnkiwwpec-unsplash_4

AstraZeneca’s Lynparza approved by NHS England

April 6, 2023
Medical Communications

NHS England has approved the use of AstraZeneca’s Lynparza (olaparib) for the treatment of patients with breast cancer and prostate …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026